Global Biologics and Biosimilars Market Research Report 2022 (Status and Outlook)

Global Biologics and Biosimilars Market Research Report 2022 (Status and Outlook)

Report Overview:

A biologic is a medicine made using a living system, and historically this was often an animal. Most products being developed as biosimilars are recombinant proteins, or proteins derived from genetically engineered DNA. In this report is a biologic defined as proteins, peptides, hormones or antibodies drugs production by bio-engineered technology, but does not include a vaccine.A biosimilar in this report is a biologic medical product which is copy of an original product that is manufactured by a different company. Biosimilars are officially approved versions of original “innovator” products, and can be manufactured when the original product's patent expires.

The Global Biologics and Biosimilars Market Size was estimated at USD 191681.38 million in 2021 and is projected to reach USD 271518.20 million by 2028, exhibiting a CAGR of 5.10% during the forecast period.

Bosson Research’s latest report provides a deep insight into the global Biologics and Biosimilars market covering all its essential aspects. This ranges from macro-overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, Porter’s five forces analysis, value chain analysis, etc.

The analysis helps to shape the competition within the industries and strategies to the competitive environment in order to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of Global Biologics and Biosimilars Market.

In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Biologics and Biosimilars market in any manner.

Global Biologics and Biosimilars Market: Market Segmentation Analysis

The research report includes specific segments by region (country), by manufacturers, by Type and by Application. Market segmentation creates subsets of a market based on product type, end user or application, Geographic, and other factor. By understanding the market segments, decision maker can leverage this targeting in product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.

Key Company

Roche

Amgen

AbbVie

Sanofi-Aventis

Johnson & Johnson

Pfizer

Novo Nordisk

Eli Lilly

Novartis

Merck

3sbio

Changchun High Tech

CP Guojian

Biotech

Gelgen

Innovent

Dong Bao

Ganlee

United Laboratories

Market Segmentation (by Type)

Monoclonal Antibodies

Interferon

Erythropoietin

Insulin

Vaccines

Others

Market Segmentation (by Application)

Tumor

Diabetes

Cardiovascular

Hemophilia

Geographic Segmentation

North America (USA, Canada, Mexico)

Europe (Germany, UK, France, Russia, Italy, Rest of Europe)

Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)

South America (Brazil, Argentina, Columbia, Rest of South America)

Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)

Key Benefits of This Market Research:

Industry drivers, restraints, and opportunities covered in the study

Neutral perspective on the market performance

Recent industry trends and developments

Competitive landscape & strategies of key players

Potential & niche segments and regions exhibiting promising growth covered

Historical, current, and projected market size, in terms of value

In-depth analysis of the market

Overview of the regional outlook of the market:

Key Reasons to Buy this Report:

Access to up to date statistics compiled by our own researchers. These provide you with historical and forecast data, which is analysed to tell you why your market is set to change

This enables you to anticipate market changes in order to remain ahead of your competitors

You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentation or other strategic documents

The concise analysis, clear graph and table format will enable you to pin point the information your require quickly

Provision of market value (USD Billion) data for each segment and sub-segment

Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market

Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region

Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled

Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players

The current as well as the future market outlook of the industry with respect to recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions

Includes in-depth analysis of the market of various perspectives through Porter’s five forces analysis

Provides insight into the market through Value Chain

Market dynamics scenario, along with growth opportunities of the market in the years to come

6-month post-sales analyst support

Customization of the Report

In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are meet.


1 Research Methodology and Statistical Scope
1.1 Market Definition and Statistical Scope of Biologics and Biosimilars
1.2 Key Market Segments
1.2.1 Biologics and Biosimilars Segment by Type
1.2.2 Biologics and Biosimilars Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 Biologics and Biosimilars Market Overview
2.1 Global Market Overview
2.1.1 Global Biologics and Biosimilars Market Size (M USD) Estimates and Forecasts (2017-2028)
2.1.2 Global Biologics and Biosimilars Sales Estimates and Forecasts (2017-2028)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 Biologics and Biosimilars Market Competitive Landscape
3.1 Global Biologics and Biosimilars Sales by Manufacturers (2017-2022)
3.2 Global Biologics and Biosimilars Revenue Market Share by Manufacturers (2017-2022)
3.3 Biologics and Biosimilars Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global Biologics and Biosimilars Average Price by Manufacturers (2017-2022)
3.5 Manufacturers Biologics and Biosimilars Sales Sites, Area Served, Product Type
3.6 Biologics and Biosimilars Market Competitive Situation and Trends
3.6.1 Biologics and Biosimilars Market Concentration Rate
3.6.2 Global 5 and 10 Largest Biologics and Biosimilars Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 Biologics and Biosimilars Industry Chain Analysis
4.1 Biologics and Biosimilars Industry Chain Analysis
4.2 Market Overview and Market Concentration Analysis of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 The Development and Dynamics of Biologics and Biosimilars Market
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 Biologics and Biosimilars Market Segmentation by Type
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Biologics and Biosimilars Sales Market Share by Type (2017-2022)
6.3 Global Biologics and Biosimilars Market Size Market Share by Type (2017-2022)
6.4 Global Biologics and Biosimilars Price by Type (2017-2022)
7 Biologics and Biosimilars Market Segmentation by Application
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Biologics and Biosimilars Market Sales by Application (2017-2022)
7.3 Global Biologics and Biosimilars Market Size (M USD) by Application (2017-2022)
7.4 Global Biologics and Biosimilars Sales Growth Rate by Application (2017-2022)
8 Biologics and Biosimilars Market Segmentation by Region
8.1 Global Biologics and Biosimilars Sales by Region
8.1.1 Global Biologics and Biosimilars Sales by Region
8.1.2 Global Biologics and Biosimilars Sales Market Share by Region
8.2 North America
8.2.1 North America Biologics and Biosimilars Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Biologics and Biosimilars Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific Biologics and Biosimilars Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Biologics and Biosimilars Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Biologics and Biosimilars Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 Key Companies Profiled
9.1 Roche
9.1.1 Roche Biologics and Biosimilars Basic Information
9.1.2 Roche Biologics and Biosimilars Product Overview
9.1.3 Roche Biologics and Biosimilars Product Market Performance
9.1.4 Roche Business Overview
9.1.5 Roche Biologics and Biosimilars SWOT Analysis
9.1.6 Roche Recent Developments
9.2 Amgen
9.2.1 Amgen Biologics and Biosimilars Basic Information
9.2.2 Amgen Biologics and Biosimilars Product Overview
9.2.3 Amgen Biologics and Biosimilars Product Market Performance
9.2.4 Amgen Business Overview
9.2.5 Amgen Biologics and Biosimilars SWOT Analysis
9.2.6 Amgen Recent Developments
9.3 AbbVie
9.3.1 AbbVie Biologics and Biosimilars Basic Information
9.3.2 AbbVie Biologics and Biosimilars Product Overview
9.3.3 AbbVie Biologics and Biosimilars Product Market Performance
9.3.4 AbbVie Business Overview
9.3.5 AbbVie Biologics and Biosimilars SWOT Analysis
9.3.6 AbbVie Recent Developments
9.4 Sanofi-Aventis
9.4.1 Sanofi-Aventis Biologics and Biosimilars Basic Information
9.4.2 Sanofi-Aventis Biologics and Biosimilars Product Overview
9.4.3 Sanofi-Aventis Biologics and Biosimilars Product Market Performance
9.4.4 Sanofi-Aventis Business Overview
9.4.5 Sanofi-Aventis Biologics and Biosimilars SWOT Analysis
9.4.6 Sanofi-Aventis Recent Developments
9.5 Johnson & Johnson
9.5.1 Johnson & Johnson Biologics and Biosimilars Basic Information
9.5.2 Johnson & Johnson Biologics and Biosimilars Product Overview
9.5.3 Johnson & Johnson Biologics and Biosimilars Product Market Performance
9.5.4 Johnson & Johnson Business Overview
9.5.5 Johnson & Johnson Biologics and Biosimilars SWOT Analysis
9.5.6 Johnson & Johnson Recent Developments
9.6 Pfizer
9.6.1 Pfizer Biologics and Biosimilars Basic Information
9.6.2 Pfizer Biologics and Biosimilars Product Overview
9.6.3 Pfizer Biologics and Biosimilars Product Market Performance
9.6.4 Pfizer Business Overview
9.6.5 Pfizer Recent Developments
9.7 Novo Nordisk
9.7.1 Novo Nordisk Biologics and Biosimilars Basic Information
9.7.2 Novo Nordisk Biologics and Biosimilars Product Overview
9.7.3 Novo Nordisk Biologics and Biosimilars Product Market Performance
9.7.4 Novo Nordisk Business Overview
9.7.5 Novo Nordisk Recent Developments
9.8 Eli Lilly
9.8.1 Eli Lilly Biologics and Biosimilars Basic Information
9.8.2 Eli Lilly Biologics and Biosimilars Product Overview
9.8.3 Eli Lilly Biologics and Biosimilars Product Market Performance
9.8.4 Eli Lilly Business Overview
9.8.5 Eli Lilly Recent Developments
9.9 Novartis
9.9.1 Novartis Biologics and Biosimilars Basic Information
9.9.2 Novartis Biologics and Biosimilars Product Overview
9.9.3 Novartis Biologics and Biosimilars Product Market Performance
9.9.4 Novartis Business Overview
9.9.5 Novartis Recent Developments
9.10 Merck
9.10.1 Merck Biologics and Biosimilars Basic Information
9.10.2 Merck Biologics and Biosimilars Product Overview
9.10.3 Merck Biologics and Biosimilars Product Market Performance
9.10.4 Merck Business Overview
9.10.5 Merck Recent Developments
9.11 3sbio
9.11.1 3sbio Biologics and Biosimilars Basic Information
9.11.2 3sbio Biologics and Biosimilars Product Overview
9.11.3 3sbio Biologics and Biosimilars Product Market Performance
9.11.4 3sbio Business Overview
9.11.5 3sbio Recent Developments
9.12 Changchun High Tech
9.12.1 Changchun High Tech Biologics and Biosimilars Basic Information
9.12.2 Changchun High Tech Biologics and Biosimilars Product Overview
9.12.3 Changchun High Tech Biologics and Biosimilars Product Market Performance
9.12.4 Changchun High Tech Business Overview
9.12.5 Changchun High Tech Recent Developments
9.13 CP Guojian
9.13.1 CP Guojian Biologics and Biosimilars Basic Information
9.13.2 CP Guojian Biologics and Biosimilars Product Overview
9.13.3 CP Guojian Biologics and Biosimilars Product Market Performance
9.13.4 CP Guojian Business Overview
9.13.5 CP Guojian Recent Developments
9.14 Biotech
9.14.1 Biotech Biologics and Biosimilars Basic Information
9.14.2 Biotech Biologics and Biosimilars Product Overview
9.14.3 Biotech Biologics and Biosimilars Product Market Performance
9.14.4 Biotech Business Overview
9.14.5 Biotech Recent Developments
9.15 Gelgen
9.15.1 Gelgen Biologics and Biosimilars Basic Information
9.15.2 Gelgen Biologics and Biosimilars Product Overview
9.15.3 Gelgen Biologics and Biosimilars Product Market Performance
9.15.4 Gelgen Business Overview
9.15.5 Gelgen Recent Developments
9.16 Innovent
9.16.1 Innovent Biologics and Biosimilars Basic Information
9.16.2 Innovent Biologics and Biosimilars Product Overview
9.16.3 Innovent Biologics and Biosimilars Product Market Performance
9.16.4 Innovent Business Overview
9.16.5 Innovent Recent Developments
9.17 Dong Bao
9.17.1 Dong Bao Biologics and Biosimilars Basic Information
9.17.2 Dong Bao Biologics and Biosimilars Product Overview
9.17.3 Dong Bao Biologics and Biosimilars Product Market Performance
9.17.4 Dong Bao Business Overview
9.17.5 Dong Bao Recent Developments
9.18 Ganlee
9.18.1 Ganlee Biologics and Biosimilars Basic Information
9.18.2 Ganlee Biologics and Biosimilars Product Overview
9.18.3 Ganlee Biologics and Biosimilars Product Market Performance
9.18.4 Ganlee Business Overview
9.18.5 Ganlee Recent Developments
9.19 United Laboratories
9.19.1 United Laboratories Biologics and Biosimilars Basic Information
9.19.2 United Laboratories Biologics and Biosimilars Product Overview
9.19.3 United Laboratories Biologics and Biosimilars Product Market Performance
9.19.4 United Laboratories Business Overview
9.19.5 United Laboratories Recent Developments
10 Biologics and Biosimilars Market Forecast by Region
10.1 Global Biologics and Biosimilars Market Size Forecast
10.2 Global Biologics and Biosimilars Market Forecast by Region
10.2.1 North America Market Size Forecast by Country
10.2.2 Europe Biologics and Biosimilars Market Size Forecast by Country
10.2.3 Asia Pacific Biologics and Biosimilars Market Size Forecast by Region
10.2.4 South America Biologics and Biosimilars Market Size Forecast by Country
10.2.5 Middle East and Africa Forecasted Consumption of Biologics and Biosimilars by Country
11 Forecast Market by Type and by Application (2022-2028)
11.1 Global Biologics and Biosimilars Market Forecast by Type (2022-2028)
11.1.1 Global Forecasted Sales of Biologics and Biosimilars by Type (2022-2028)
11.1.2 Global Biologics and Biosimilars Market Size Forecast by Type (2022-2028)
11.1.3 Global Forecasted Price of Biologics and Biosimilars by Type (2022-2028)
11.2 Global Biologics and Biosimilars Market Forecast by Application (2022-2028)
11.2.1 Global Biologics and Biosimilars Sales (K Units) Forecast by Application
11.2.2 Global Biologics and Biosimilars Market Size (M USD) Forecast by Application (2022-2028)
12 Conclusion and Key Findings

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings